中航西飛(000768.SZ):是ARJ21飛機的機體結構主要供應商,C919飛機的機體結構重要供應商
格隆匯2月1日丨中航西飛(000768.SZ)於2024年2月1日接受特定對象調研,就“公司民機業務未來的發展情況如何?”,公司回覆稱,大型客機的成功交付客户將為民機產業迎來更為廣闊的發展空間,公司對民機產業未來的發展充滿信心。公司作為中國商飛的核心供應商之一,是ARJ21飛機的機體結構主要供應商,C919飛機的機體結構重要供應商,目前C919飛機和ARJ21飛機項目生產能力穩定,對標中國商飛計劃需求完成部件配套,以支持中國商飛滿足最終用户的訂單及運營需求,未來能夠滿足中國商飛的採購需求,在保障產品高質量準時交付的前提下,將與中國商飛持續緊密合作,實現共贏。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.